Characteristics | Group I (n = 19) PRE+FOE+nutritional supplement | Group II (n = 21) PRE+FOE + placebo | Group III (n = 19) SE+FOE+nutritional supplement | Group IV (n = 21) SE+FOE + placebo |
---|---|---|---|---|
Age, mean ± SD | 78.1 ± 7.6 | 79.2 ± 9.2 | 78.3 ± 6.8 | 81.1 ± 6.4 |
Female sex (%) | 84 | 81 | 74 | 81 |
Height (cm) mean ± SD | 159 ± 5.3 | 160 ± 8.7 | 159 ± 7.5 | 158 ± 9.3 |
Weight (kg) mean ± SD | 62.2 ± 13.2 | 63.4 ± 12.1 | 63.8 ± 12.3 | 63.9 ± 11.2 |
Systolic blood pressure (mmHg) | 138 ± 9.9 | 129 ± 18.1 | 136 ± 17.5 | 140 ± 18.1 |
Diastolic blood pressure (mmHg) | 85 ± 7.9 | 80 ± 9.5 | 81 ± 7.0 | 82 ± 9.5 |
Heart rate mean ± SD | 77 ± 9.3 | 75 ± 6.5 | 76 ± 4.8 | 76 ± 10.5 |
Diagnoses/medications | Â | Â | Â | Â |
Cardiovascular diseases (%) | 79 | 67 | 74 | 76 |
Pulmonary disorders (%) | 53 | 48 | 58 | 52 |
Locomotive disorders (%) | 63 | 62 | 68 | 67 |
Neurological disorders (%) | 37 | 38 | 32 | 43 |
Urinary system diseases (%) | 21 | 19 | 26 | 24 |
Visual deficits (%) | 47 | 43 | 42 | 38 |
Regular medications Mean ± SD | 8.3 ± 5.6 | 9.1 ± 4.4 | 8.6 ± 5.1 | 9.4 ± 4.6 |
Key inclusion criteria | Â | Â | Â | Â |
Berg Balance Scale (0–56) mean ± SD | 45 ± 9.5 | 47 ± 8.2 | 46 ± 8.3 | 44 ± 9.2 |
MMSE (0–30) mean ± SD | 23.8 ± 3.7 | 23.5 ± 4.5 | 24.7 ± 5.9 | 23.7 ± 4.0 |
Nutritional status | Â | Â | Â | Â |
BMI (kg/m2) mean ± SD | 24.7 ± 0.8 | 24.3 ± 0.6 | 25.2 ± 0.7 | 25.2 ± 0.6 |
MNA score (0–30) mean ± SD | 22.1 ± 2.6 | 23.1 ± 2.5 | 23.3 ± 2.2 | 22.4 ± 2.2 |
Na mmol/l mean ± SD | 142.8 ± 5.1 | 143.8 ± 1.9 | 144.1 ± 2.7 | 143 ± 2.7 |
K mmol/l mean ± SD | 4.1 ± 0.4 | 4.2 ± 0.5 | 4.1 ± 0.4 | 4.3 ± 0.5 |
Ca mmol/l mean ± SD | 1.8 ± 0.6 | 2.1 ± 0.7 | 1.8 ± 0.7 | 1.8 ± 0.7 |
Glucose mmol/l mean ± SD | 4.9 ± 0.57 | 4.8 ± 0.57 | 4.8 ± 0.54 | 4.9 ± 0.86 |
Total cholesterol mol/l mean ± SD | 5.09 ± 1.57 | 6.35 ± 1.04 | 5.54 ± 1.07 | 6.07 ± 1.02 |
LDL mmol/l mean ± SD | 3.45 ± 1.2 | 4.25 ± 1.0 | 3.92 ± 0.9 | 4.18 ± 0.9 |
HDL mmol/l mean ± SD | 1.44 ± 0.4 | 1.65 ± 0.6 | 1.45 ± 0.4 | 1.39 ± 0.5 |
Functional capability | Â | Â | Â | Â |
ADL (0–6) mean ± SD | 5.4 ± 0.8 | 5.5 ± 0.8 | 5.4 ± 1.0 | 4.9 ± 1.1 |
IADL (0–27) mean ± SD | 20.8 ± 5.4 | 21.4 ± 5.5 | 20.7 ± 4.8 | 20.1 ± 4.7 |
Tinetti Total score (0–28) Mean ± SD | 22.3 ± 5.3 | 23.8 ± 4.1 | 22.5 ± 5.6 | 20.9 ± 4.8 |
Tinetti Balance score (0–16) mean ± SD | 12.5 ± 3.1 | 13.6 ± 2.2 | 13.1 ± 3.5 | 11.0 ± 3.0 |
Tinetti Gait score (0–12) Mean ± SD | 9.7 ± 3.0 | 10.2 ± 2.2 | 9.4 ± 2.5 | 9.9 ± 2.6 |
6 MW test (m.) mean ± SD | 267 ± 129 | 222 ± 103 | 262 ± 106 | 228 ± 107 |
Use walking aids (%) | 42 | 48 | 47 | 43 |
Muscle strength (N/m.) | Â | Â | Â | Â |
Right leg | Â | Â | Â | Â |
Knee flexion mean ± SD | 18.1 ± 7.0 | 18.5 ± 6.4 | 17.7 ± 5.3 | 18.6 ± 6.3 |
Knee extension mean ± SD | 33 ± 12.7 | 36 ± 9.9 | 34.5 ± 13.4 | 33.5 ± 10.9 |
Hip flexion mean ± SD | 27.1 ± 12.6 | 29.9 ± 13.2 | 29.6 ± 9.6 | 28.5 ± 9.6 |
Hip extension mean ± SD | 21.2 ± 7.3 | 21.3 ± 8.5 | 20.2 ± 8.5 | 20.3 ± 8.2 |
Left leg | Â | Â | Â | Â |
Knee flexion mean ± SD | 18.3 ± 6.5 | 17.9 ± 5.8 | 17.7 ± 5.2 | 18.9 ± 6.7 |
Knee extension mean ± SD | 33.6 ± 13.6 | 36.8 ± 13.0 | 33.1 ± 12.2 | 34.9 ± 13.8 |
Hip flexion mean ± SD | 29.8 ± 10.5 | 31.9 ± 11.8 | 31.1 ± 13.1 | 30.5 ± 10.6 |
Hip extension mean ± SD | 22.4 ± 7.3 | 22 ± 9.9 | 21.6 ± 5.9 | 22.1 ± 7.4 |